ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VEC Vectura Group Plc

164.80
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vectura Group Plc LSE:VEC London Ordinary Share GB00BKM2MW97 ORD 0.0271P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 164.80 164.80 165.00 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Vectura Share Discussion Threads

Showing 10326 to 10347 of 12050 messages
Chat Pages: Latest  422  421  420  419  418  417  416  415  414  413  412  411  Older
DateSubjectAuthorDiscuss
30/9/2020
10:40
Is that ‘bull’ as in a load of.....
diesel
30/9/2020
10:39
Exactly - bull!
alexchry
30/9/2020
09:54
Nice buying opportunity for me at these levels, remember the Numis bull case is 250p......
chrisdgb
29/9/2020
19:01
And there's the problem. Sell the shares, and the court case is won and you miss the rise OR keep the shares and the case is lost and down you go. As I stated earlier it has now become a binary stock based on this single event. Only you can make the decision.
cockneytrader
29/9/2020
14:03
£80 million in the bank and absolutely no vision going forward. You may as well put a chimpanzee in charge and pay it in bananas.
cockneytrader
29/9/2020
13:19
CT - even if approved it will have been nearly four years since getting initial rejection, I should have sold then for 130+ but never expected it to take so long to get resubmission approved and that's by no means certain. The court case is another thing that's dragged on longer than expected, unfortunately, which has not helped the share price
alexchry
29/9/2020
11:48
A1, without significant generic Advair success there can't be much hope for the next generation of generic Ellipta products. The court case is a decision to be made by the appeal court so out of everyone's hands.

Diesel, what's changed medium term is that Advair wasn't approved for a second time. That's a pretty fundamental error when you are in the business of generics!

cockneytrader
29/9/2020
11:36
Funny, when it’s rising, it’s worth 200p, when it’s falling its a sell, watch the trend, erratic but it has been rising steadily for 18mnths. See no change in medium term prospects, but I must admit the new management team haven’t yet delivered....
diesel
29/9/2020
11:24
CT , long term without GSK win and Advair, its SELL, because management statement was for me discouraging - going from big business to 2-3 mil £ business is huge step back down - degeneration IMHP !
Level of the company downgraded !
Very disappointed with new CEO and his no vision !
Hope some one will buy VEC and fire all these rats !
Have a big doubts about capability of Vectura to develop generic Elipta after so many failures with Advair!
All league one products are back now in the past time - time of SKP and old Vectura !
Mylan didnt design Advair . Advair designed by Vectura , but Vectura failed until now to get FDA Advair approval and Mylan got it .
For me looks like they(Vec) just incapable !

PS Polaris, what is your opinion on Advair multi failure ?

a1ord53
29/9/2020
11:19
Funds have no more info than you or I - apparently the authorities would be a bit concerned if they did!
aceuk
29/9/2020
10:56
Blackrock buying in should have been a positive here. 5% drop on what news exactly?
justiceforthemany
29/9/2020
10:23
Yes she would have been privy to some confidential matters concerning contracts etc. Very poor judgment on behalf of the Board, which I find a little concerning.
jimboyce
29/9/2020
10:10
What I trying to say is that it's feels like a bit of a gamble. Ask yourself what's the upside on a win vs. a downside on a loss. I would suggest 20% + on a win and 40% (-) on a loss.
cockneytrader
29/9/2020
10:06
It's starting to feel like a binary stock. Win the court case GOOD or lose the court case VERY BAD and all out of our hands.
cockneytrader
29/9/2020
09:52
Out of fire power. Expect these to continue to drift down on no news. Polaris, your 80p entry may yet once again become reality. Will most definitely require Advair approval and court case win in the new year to reach new highs.
cockneytrader
29/9/2020
08:43
Had to put 2 orders in.
Anyway, Vectura has plenty of upside potential IMO

peddlers
29/9/2020
08:33
My new broker would only allow me 20,000 shares
Must call them as that is hopeless

peddlers
29/9/2020
08:21
Must admit I didn’t realise the connection with Aerami, thought, foolishly, that the new strengthened marketing team had scoured the pharma world for a partner for its shelved VR325 candidate, and then see that a board member is CEO of the new partner. Not impressed!
diesel
29/9/2020
08:21
I think there is high growth potential in this industry.
VEC could pull back a bit so I am just about to place a buy order this moring for 40,000 at 98p.

peddlers
29/9/2020
07:04
10% almost down since entry into FTSE 250 ,modest management update plus Advair delay :(
They should continue buy back or pay some divi imo.

a1ord53
29/9/2020
06:41
Second tranche of buyback completed
gbcol
25/9/2020
04:56
Vectura shortlisted for ’Excellence in Pharma: Contract Services and Outsourcing’
Published:24/09/2020

taffy100
Chat Pages: Latest  422  421  420  419  418  417  416  415  414  413  412  411  Older

Your Recent History

Delayed Upgrade Clock